Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for nivolumab and vismodegib in patients with basal cell nevus syndrome is now displayed, including its study design and eligibility details. The record indicates that the study was withdrawn due to loss of funding.SummaryDifference49%

- Check15 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0 in the page footer.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH announcement appears above the page, linking to updates about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now displays a 403 Forbidden message, indicating that access to the record is blocked. The page shows standard site chrome around the error content, rather than the study details.SummaryDifference19%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.